A SBIR Phase I contract was awarded to Koya Medical in August, 2020 for $224,957.0 USD from the National Science Foundation.
The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to address needs related to lymphedema. Lymphedema is a common and lifelong side-effect of cancer surgery that occurs from injury or damage to lymphatics, affecting a